FDA orphan drug designation: treatment of idiopathic pulmonary fibrosis
All entries for: Chiesi Farmaceutici S.p.A.
November 25, 2025
Chiesi Farmaceutici S.p.A.
Orphan Drug Designation
Disease Area: Rare Diseases
FDA orphan drug designation: treatment of idiopathic pulmonary fibrosis